Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.31 |
| ▸ | PTPRF | P10586 | 1/20 | 0.31 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22151194 | 0.81 | ALOX5 (0.46) | ALOX5GGPS1HDAC8 | |
| SCHEMBL15499236 | 0.78 | BCAT1 (0.35) | ALOX5 | |
| SCHEMBL25632416 | 0.74 | ALOX5 (0.38) | ALOX5GGPS1PTPRFPTPN2PTPN1 | |
| SCHEMBL23438818 | 0.74 | ALOX5 (0.49) | ALOX5GGPS1HDAC8 | |
| SCHEMBL23438796 | 0.73 | ALOX5 (0.48) | ALOX5GGPS1HDAC8 | |
| SCHEMBL21588549 | 0.73 | ALOX5 (0.50) | ALOX5GGPS1 | |
| SCHEMBL22059162 | 0.72 | ALOX5 (0.49) | ALOX5GGPS1HDAC8 | |
| SCHEMBL25000230 | 0.71 | ALOX5 (0.49) | ALOX5GGPS1HDAC8 | |
| SCHEMBL23438797 | 0.71 | ALOX5 (0.51) | ALOX5GGPS1HDAC8 | |
| SCHEMBL25628869 | 0.71 | ALOX5 (0.46) | ALOX5GGPS1HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210163411-A1 | COMPOUND HAVING TRIARYLAMINE STRUCTURE AS CORE, AND PREPARATION METHOD THEREFOR | JIANGSU SUNERA TECHNOLOGY CO., LTD. (CN) | 2021-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210163411-A1 | COMPOUND HAVING TRIARYLAMINE STRUCTURE AS CORE, AND PREPARATION METHOD THEREFOR | WEE1, WEE2, ALOX12 | ALOX5 41/4885GGPS1 72/4885PTPRF 4076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.